Hana Pharm하나제약
293480 · KOSPI · ₩293480 · 하나제약
₩8,230▲ ₩60 (0.73%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 60.7% | 60.5% | 62.7% | 62.2% | 62.2% | 66.6% |
| Operating margin | 11.5% | 10.8% | 11.2% | 12.0% | 14.8% | 18.3% |
| Net margin | 4.7% | 3.7% | 9.4% | 9.9% | 11.5% | 14.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +3.3% | +6.3% | +0.4% | +6.5% | +7.4% | — |
| Operating income growth | +10.6% | +2.6% | −6.9% | −13.3% | −13.4% | — |
| Net income growth | +33.3% | −58.7% | −4.8% | −8.1% | −13.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 3.6% | 2.8% | 7.2% | 8.2% | 9.3% | 11.1% |
| Return on assets | 2.7% | 2.2% | 5.8% | 6.4% | 7.5% | 9.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 34.6% | 33.4% | 23.6% | 25.3% | 28.9% | 20.5% |
| Net debt to equity | 16.3% | 14.8% | 6.0% | 7.9% | 6.7% | 0.4% |
| Current ratio | 195.7% | 183.6% | 333.0% | 182.5% | 231.6% | 343.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Hana Pharm / 하나제약 / 293480 / KRX:293480
Source: KRX statistical information